GLP1R and gallstones: Across the full cohort (n = 119), the distribution was gallstones 49.6% (59/119), GLP-1 agonists 1.7% (2/119), idiopathic 22.7% (27/119), autoimmune 8.4% (10/119), and alcohol 5.9% (7/119).